跳至主要内容
临床试验/ACTRN12620000190909
ACTRN12620000190909已完成未知

A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: The FLASH-2 Study

Starship Children’s Health0 个研究点目标入组 107 人开始时间: 2020年2月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
107

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
4 Years 至 13 Years(—)
性别
All

入选标准

  • 1. Children aged 4 to less than or equal to 13 years;
  • 2. A diagnosis of T1D for 6 months or longer duration;
  • 3. Current HbA1c greater than or equal to 58 mmol/mol and less than or equal to 110 mmol/mol;
  • 4. On an insulin dose per day > 0.05 units of insulin/kg/day;
  • 5. No regular use of flash glucose monitoring (FGM) or continuous glucose monitoring (CGM) in the previous 3 months.

排除标准

  • There will be no restriction on insulin regimen.
  • 1.Any severe chronic diabetes-related complications;
  • 2.Severe medical or psychiatric co-morbidity/severe mental illness;
  • 3.Participation in another study that could affect glucose measurements;
  • 4.Plans to leave study site regions prior to study completion;
  • 5.Regular continuous use of FGM or CGM;
  • 6.HbA1c > 110mmol/mol.

研究者

发起方
Starship Children’s Health

相似试验